GEMOAB MONOCLONALS GMBH NOVEL IMMUNOTHERAPEUTIC CONCEPTS
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

GEMOAB MONOCLONALS GMBH NOVEL IMMUNOTHERAPEUTIC CONCEPTS Trademark

Serial Number: 86544464 • Registration: 5268692

GEMOAB MONOCLONALS GMBH NOVEL IMMUNOTHERAPEUTIC CONCEPTS is a trademark filed by Cellex Gesellschaft für Zellgewinnung mbH on February 24, 2015. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Cellex Gesellschaft für Zellgewinnung mbH (3 trademarks)

Fiedlerstraße 36

Entity Type: 99

Trademark Details

Filing Date

February 24, 2015

Registration Date

August 22, 2017

Published for Opposition

June 6, 2017

Cancellation Date

March 8, 2024

Goods & Services

Business management and organization consultancy; Business consulting services; Advisory services for business management; Consultancy relating to business organisation; Personnel management consultancy; Business investigation; Logistics management in the field of medicine

Blood bank services

Technical advice and consultancy in the field of biotechnology, medical technology and information technology; Scientific consultancy in the field of biotechnology; Scientific consultancy in the field of medical technology; Scientific consultancy in the field of information technology; Chemical research, for others; Biotechnology research, for others; Medical technology research, for others

Filing History

CANCELLED SEC. 8 (6-YR)
Mar 8, 2024 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 22, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 22, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 4, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 2, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 2, 2017 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 28, 2017 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 2, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 2, 2016 GNSL
SUSPENSION LETTER WRITTEN
Nov 2, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2016 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 7, 2016 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 9, 2016 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 9, 2016 GNSI
SUSPENSION INQUIRY WRITTEN
May 9, 2016 CNSI
ASSIGNED TO LIE
May 6, 2016 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 2, 2015 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 2, 2015 GNSL
SUSPENSION LETTER WRITTEN
Nov 2, 2015 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 29, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 28, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 28, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jun 2, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2015 CNRT
ASSIGNED TO EXAMINER
Jun 1, 2015 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 11, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2015 NWOS
NEW APPLICATION ENTERED
Feb 27, 2015 NWAP